Cargando…
Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics
Antibiotic development based on natural products has faced a long lasting decline since the 1970s, while both the speed and the extent of antimicrobial resistance (AMR) development have been severely underestimated. The discovery of antimicrobial natural products of bacterial and fungal origin featu...
Autores principales: | Panter, Fabian, Bader, Chantal D., Müller, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098685/ https://www.ncbi.nlm.nih.gov/pubmed/33995996 http://dx.doi.org/10.1039/d0sc06919a |
Ejemplares similares
-
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering
por: Groß, Sebastian, et al.
Publicado: (2021) -
The Sandarazols are Cryptic and Structurally Unique Plasmid‐Encoded Toxins from a Rare Myxobacterium
por: Panter, Fabian, et al.
Publicado: (2021) -
Self-resistance guided genome mining uncovers new topoisomerase inhibitors from myxobacteria
por: Panter, Fabian, et al.
Publicado: (2018) -
Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics
por: Hollmann, Axel, et al.
Publicado: (2018) -
Concepts and Methods to Access Novel Antibiotics from Actinomycetes
por: Hug, Joachim J., et al.
Publicado: (2018)